Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS)

Table 3 Linear regression analyses of MetS and depression (N = 14.416–14.499 ^a)

	Depressive symptoms (PHQ)	Somatic-affective symptoms	Cognitive-affective symptoms
	B (95% CI)	B (95% CI)	B (95% CI)
Model 1	0.008 (− 0.004/ 0.020) p = .188	0.020 (0.011/ 0.028) p < .001	−0.020 (− 0.036/ -0.005) p = .011
Model 2	0.028 (0.016/ 0.041) p < .001	0.034 (0.025/ 0.043) p < .001	0.000 (− 0.016/ 0.016) p = .995
Model 3	0.014 (0.003/ 0.026) p < .015	0.024 (0.015/ 0.032) p < .001	−0.015 (− 0.030/ 0.000) p = .056
Model 4	–	0.026 (0.018/ 0.033) p < .001	−0.037 (− 0.050/ -0.023) p < .001

Model 1: without adjustment; Model 2: adjusted for age, sex and socioeconomic status (SES); Model 3: additionally adjusted for somatic conditions (CHD, atrial fibrillation, cancer, myocardial infarction, stroke, PAOD), any anxiety, and psychotropic medication; Model 4: additionally adjusted for cognitive-affective symptoms (dependent variable: somatic-affective symptoms), respectively for somatic-affective symptoms (dependent variable: cognitive-affective symptoms)
^aN ranges between 13.363 and 14.499 because of missing data

ISSN: 1471-244X